The practice of evaluating epidemic response in humanitarian and low-income settings: a systematic review. by Warsame, Abdihamid et al.
RESEARCH ARTICLE Open Access
The practice of evaluating epidemic
response in humanitarian and low-income
settings: a systematic review
Abdihamid Warsame* , Jillian Murray, Amy Gimma and Francesco Checchi
Abstract
Background: Epidemics of infectious disease occur frequently in low-income and humanitarian settings and pose a
serious threat to populations. However, relatively little is known about responses to these epidemics. Robust
evaluations can generate evidence on response efforts and inform future improvements. This systematic review
aimed to (i) identify epidemics reported in low-income and crisis settings, (ii) determine the frequency with which
evaluations of responses to these epidemics were conducted, (iii) describe the main typologies of evaluations
undertaken and (iv) identify key gaps and strengths of recent evaluation practice.
Methods: Reported epidemics were extracted from the following sources: World Health Organization Disease
Outbreak News (WHO DON), UNICEF Cholera platform, Reliefweb, PROMED and Global Incidence Map. A systematic
review for evaluation reports was conducted using the MEDLINE, EMBASE, Global Health, Web of Science, WPRIM,
Reliefweb, PDQ Evidence and CINAHL Plus databases, complemented by grey literature searches using Google and
Google Scholar. Evaluation records were quality-scored and linked to epidemics based on time and place. The time
period for the review was 2010–2019.
Results: A total of 429 epidemics were identified, primarily in sub-Saharan Africa, the Middle East and Central Asia.
A total of 15,424 potential evaluations records were screened, 699 assessed for eligibility and 132 included for
narrative synthesis. Only one tenth of epidemics had a corresponding response evaluation. Overall, there was wide
variability in the quality, content as well as in the disease coverage of evaluation reports.
Conclusion: The current state of evaluations of responses to these epidemics reveals large gaps in coverage and
quality and bears important implications for health equity and accountability to affected populations. The limited
availability of epidemic response evaluations prevents improvements to future public health response. The diversity
of emphasis and methods of available evaluations limits comparison across responses and time. In order to improve
future response and save lives, there is a pressing need to develop a standardized and practical approach as well as
governance arrangements to ensure the systematic conduct of epidemic response evaluations in low-income and
crisis settings.
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Background
Infectious disease epidemics continue to pose a substan-
tial risk globally [1]. Epidemics routinely occur in low-
income and humanitarian settings [2]. Populations in
these settings often do not have the resources to effect-
ively respond to epidemics [3] and as a result are at
higher risk of increased morbidity and mortality [4].
Globally, more than 700 million people live in low-
income countries [5], while 2 billion live in fragile or
conflict-affected settings [6]. Responses to large-scale
epidemics or epidemics of newly emergent pathogens
tend to generate global attention and corresponding
responses incur scrutiny [7–9]. However, evidence on
responses to smaller-scale epidemics or epidemics in-
volving well-known pathogens (e.g. measles, cholera) for
which effective control measures exist is thought to be
limited [10]. Evidence from some limited contexts points
to weaknesses in responses ranging from detection, in-
vestigation to effective and timely response [11, 12].
However, the practice of epidemic response evaluation
has not been systematically assessed in low-income and
humanitarian settings. Within public health program-
ming, effective evaluations generate critical evidence and
allow for systematic understanding, improvement and
accountability of health action [13]. We sought to review
the extent to which evaluations of epidemic responses
are actually conducted in low-income and crisis settings
and describe key patterns in evaluation practice. Specif-
ically, we aimed to (i) identify epidemics reported in
low-income and crisis settings, by aetiologic agent, over
a recent period; (ii) determine the frequency with which
evaluations of responses to these epidemics were con-
ducted; (iii) describe the main typologies of evaluations
undertaken; and (iv) identify key gaps and strengths of
recent evaluation practice, so as to formulate
recommendations.
Methods
Scope of the review
This review (PROSPERO registration CRD42019150693)
focuses on recent epidemics in low-income settings, de-
fined using the 2018 World Bank criteria [14], as well as
epidemics occurring in settings with ongoing humanitar-
ian responses, as reported in the United Nations Office
for the Coordination of Humanitarian Affairs’ annual
Global Humanitarian Overview. Our search focused on
epidemic-prone pathogens commonly occurring in low
resource or humanitarian settings and which presented
an immediate threat to life. For this reason, our search
excluded HIV [15], tuberculosis [16] and Zika [17]. Epi-
demics occurring within healthcare settings only or
within animal populations were considered outside the
scope of this review. In order to capture recent trends
and assess contemporary reports, we focused on the
period 2010–2019.
Epidemics
Search strategy
The following sources were reviewed in order to compile
a list of reported epidemics: World Health Organization
Disease Outbreak News (WHO DON) [18], UNICEF
Cholera platform [19], Reliefweb [20], PROMED [21]
and Global Incidence Map [22]. In line with WHO guid-
ance on infectious disease control in emergencies [23],
one suspected case of the following was considered to be
an epidemic: acute haemorrhagic fevers (Ebola, Lassa
fever, Rift valley fever, Crimean-Congo haemorrhagic
fever), anthrax, cholera, measles, typhus, plague and
polio. For the remainder of the pathogens, we defined an
epidemic as an unusual increase in incidence relative to
a previously established baseline in a given setting.
We reviewed WHO DON narrative reports to extract
metadata on location (country), year, month and patho-
gen. Reliefweb was searched for reported epidemics
using the search engine and the disaster type filter. For
the PROMED database, only epidemics rated as 3 or
higher in the 5-point rating system (which reflected a
higher degree of certainty in the scale of the epidemic
and its potential severity) and in which incident cases
and deaths were reported were considered for inclusion.
The Global Incident Map database was searched utiliz-
ing the inbuilt search function filtering results that were
out of scope (wrong location, pathogen, etc.) at the
source.
We collated all epidemic records into a single database
and removed duplicate reports of the same epidemic
based on first date and location of occurrence; dupli-
cated included multiple reports within any given data-
base (e.g. an update on an earlier reported epidemic)
and reports of the same epidemic in multiple databases.
As phylogenetic or spatio-temporal reconstructions of
epidemics were mostly unavailable, we assumed that re-
ports of the same pathogen from within the same coun-
try and 4-month period referred to the same single
epidemic. We decided to split cross-border epidemics
(e.g. the West Africa 2013–2016 Ebola epidemic) into
one separate epidemic for each country affected, recog-
nizing that responses would have differed considerably
across these countries.
Screening and data extraction
We compiled epidemic reports from various sources into
one database. For each epidemic, information on loca-
tion (country), year, month and pathogen was extracted
using a standardized form (see Additional file 1). For
reach evaluation record, information was extracted on a
number of variables including type of evaluation,
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location (country), year, month and pathogen using a
standardized form (see Additional file 2).
Evaluations
Search strategy
To determine the availability and quality of epidemic re-
sponse evaluations within recent epidemics, we under-
took a systematic review using PRISMA criteria
including peer-reviewed and grey literature. We identi-
fied peer-reviewed reports by consulting the MEDLINE,
EMBASE, Global Health, Web of Science, Western
Pacific Region Index Medicus, PDQ Evidence and
Cumulative Index to Nursing and Allied Health Litera-
ture (CINAHL) Plus databases. We utilized Google,
Google Scholar and Reliefweb, to undertake a compre-
hensive search of the grey literature. Given previously
described challenges in using such search engines [24],
we reviewed results from the first 150 hits only. We
searched the webpages of major humanitarian and
health organizations including the World Health
Organization (WHO), United Nations Children’s Fund
(UNICEF), Save the Children, International Federation
of Red Cross and Red Crescent Societies (IFRC) and
Médecins Sans Frontières (MSF) for evaluation records
and contacted these organizations to source non-public
evaluations identified through this webpage search.
Overarching conceptual search terms synonymous with
outbreaks, evaluations and humanitarian crises were uti-
lized. The full search strategy can be found in
Additional file 3.
We cross-referenced the reported epidemics with the
evaluation reports, matching on date (month and year)
and location.
Inclusion criteria
We limited our search to any record that met the follow-
ing criteria: any document published in the period
2010–2019 in the English and French languages that ex-
amined epidemics within low-income countries and hu-
manitarian settings, as defined above. There were no
restrictions on study design.
We excluded records relying exclusively on mathemat-
ical models of potential responses as the review was
focused on responses that were operationally imple-
mented. We also excluded evaluations of a novel diag-
nostic or treatment; evaluations that focussed on
preparedness, resilience or recovery from an epidemic,
as opposed to the epidemic period itself; records ad-
dressing other health issues (e.g. reproductive health) in
the context of an epidemic; epidemiological studies of
the epidemic (e.g. transmission patterns, risk factors)
that did not explore the response; records classified as
clinical research, opinion or news pieces; and abstracts
for which full records could not be accessed.
In assessing the eligibility of records for narrative syn-
thesis, we used a broad definition of epidemic evaluation
as one in which:
I. An epidemic was reported to have occurred
II. The intervention(s) being evaluated began after the
start of the epidemic and were specifically
implemented in response to the epidemic
III. The intervention(s) were assessed on at least one
specified criterion (i.e. the report was not merely a
description of activities).
Screening and data extraction
After removing duplicates, two reviewers independ-
ently assessed the relevance of all titles and abstracts
based on the inclusion criteria. We retrieved the full
text of each article initially meeting the criteria. Two
researchers then independently confirmed that full-
text records met inclusion criteria. Any disagreements
were resolved through discussion and consensus with
a third reviewer.
We used the following definitions to classify the type
of evaluations retrieved in this search:
 Formative evaluation: Evaluation which assesses
whether a program or program activity is feasible,
appropriate and acceptable before it is fully
implemented
 Process evaluation: Evaluation which determines
whether program activities have been implemented
as intended
 Output evaluation: Evaluation which assesses
progress in short-term outputs resulting from pro-
gram implementation
 Outcome/performance evaluation: Evaluation which
assesses program effects in the target population
by measuring the progress in the outcomes or
outcome objectives that the program is meant to
achieve
 Impact evaluation: An evaluation that considers
‘positive and negative, primary and secondary
long-term effects produced by a development
intervention, directly or indirectly, intended or
unintended.’ [25]
Analysis
We undertook a narrative synthesis of the findings and
tabulated key characteristics of evaluations. We created an
evaluation quality checklist derived from existing
standards to grade the quality of the evaluation records.
Reference standards included the United Nations’
Evaluation Group (UNEG) Quality Checklist [26], the
European Commission Quality Assessment for Final
Evaluation Reports [27] and the UNICEF-Adapted UNEG
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Quality Checklist [28]. We derived 13 evaluation criteria
grouped into 4 equally weighted categories: scope,
methodology, findings and recommendations. The check-
list can be found in Additional file 3.
Role of the funding source
The funder of the study had no role in study design, data
collection, data analysis, data interpretation or writing of
the report. The corresponding author had full access to
all the data in the study and had final responsibility for
the decision to submit for publication.
Results
Epidemics
A total of 429 epidemics were identified across 40 low-
income and crisis affected countries during the study
period (Table 1). The most common pathogens reported
were Vibrio cholerae, measles, poliovirus and Lassa virus.
Epidemics were reported primarily in sub-Saharan
Africa, the Middle East and Central Asia. Generally, the
more populous countries in each region experienced the
highest number of epidemics including Nigeria and the
Democratic Republic of Congo in the AFRO region and
Pakistan and Sudan in the EMRO region.
Evaluations
A total of 15,124 records were identified and screened
based on title and abstract (Fig. 1). The full text of 699
records was assessed for eligibility. A final tally of 132
records was carried forward for cross referencing against
reported epidemics and for narrative synthesis [29–160].
See Additional file 2 for full list of included evaluations.
Evaluation characteristics
More than half of the evaluation records assessed out-
come of the response, with a substantial number of
Table 1 Number of epidemics by outbreak pathogen and World Health Organization regional office
Disease Number of epidemics by WHO regional office
AFROa EMROb EUROc PAHOd SEAROe Total
Anthrax 7 4 2 1 0 14
Brucellosis 0 1 0 0 0 1
CCHF 2 5 1 0 0 8
Chikungunya 2 2 0 1 0 5
Cholera 145 36 3 10 14 208
Dengue 6 11 1 2 11 31
Diphtheria 0 1 0 2 0 3
Ebola 16 1 0 0 1 18
Hepatitis E 2 0 0 0 0 2
Japanese Encephalitis 0 1 0 0 4 5
Lassa Fever 17 0 0 0 0 17
Leishmaniasis 3 0 0 0 0 3
Malaria 10 2 0 1 0 13
Marburg 1 0 0 0 0 1
Measles 20 6 0 1 0 27
Meningitis 8 1 0 0 0 9
Meningococcal disease 11 1 0 0 0 12
Plague 7 0 0 0 0 7
Polio 12 11 2 0 1 26
Rift Valley Fever 3 2 0 0 0 5
Typhoid 0 1 0 0 0 1
Yellow fever 11 2 0 0 0 13
Grand Total 283 88 9 18 31 429
aWHO African Regional Office
bWHO Eastern and Mediterranean Regional Office
cWHO European Regional Office
dWHO Pan American Regional Office
eWHO South East Asia Regional Office
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process and output evaluations (Table 2). Very few
evaluations could be classified as impact or formative
evaluations while 4 studies were considered to be of
mixed typology. Half of the evaluations reported (n = 66)
utilizing a mix of primary and secondary data while ap-
proximately a quarter of evaluations utilized either
mainly primary (n = 36) or secondary data (n = 30).
Additionally, more than half of evaluations (n = 78)
collected a mixture of quantitative and qualitative data
while a smaller proportion relied on either qualitative
data (n = 18) and quantitative data (n = 37). Few re-
cords (n = 9) had no explicit evaluation framework or
criteria while the majority (n = 123) did refer to some
evaluation criteria including the OECD evaluation
criteria. However, only few (n = 10) presented an
explicitly named framework which anchored the
evaluation approach. Effectiveness was the most
widely used evaluation criterion while the most widely
evaluated activities included coordination, vaccination,
contact tracing, case management and community
sensitization. See Additional file 2 for full results.
There was an improvement in the availability of evalu-
ation reports over time with fewer evaluations in the
first 3 years of the decade (n = 10) compared to the last
3 years (n = 43) (Fig. 2). Lastly, where evaluations were
published, there was an average of 2 years between the
onset of an epidemic and publication of the response
evaluation.
Quality findings
Quality scores of evaluation reports ranged from 31 to 96
on a 100-point scale. The average quality score of
Fig. 1 Evaluation records screened
Table 2 Distribution of response evaluations by type
Type of evaluation Number of evaluations
Formative 4 (3.0%)
Process 27 (20.5%)
Output 14 (10.6%)
Outcome 74 (56.0%)
Impact 9 (6.8%)
Mixed 4 (3.0%)
Total 132 (100%)
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evaluations in low-income settings was 76 compared to 68
in middle-income countries. The average quality scores of
evaluations undertaken in humanitarian versus non-
humanitarian settings did not differ substantially (76.7 vs
75.2) nor between mid-epidemic versus post epidemic
(74.4 vs 76.9). Quality scores ranged amongst disease
pathogens with the highest average quality scores for
evaluation of measles epidemics (88.4) and the lowest for
evaluations of leishmaniosis epidemics (57.6). Addition-
ally, there appeared to be an improvement in the quality
of evaluation reports over time with reports in the first 3
years of the decade averaging a score of 64 compared to a
score of 80 in the last 3 years. Although the majority of
evaluations (n = 104) did identify and utilize existing
information and documentation, few (n = 28) provided an
appraisal of quality or reliability of these data sources. For
the most part, evaluation studies did score well in present-
ing the rationale of the evaluation (average score = 0.88),
providing the contextual information (average score 0.92)
and clarifying the evaluation timeline (average score 0.82).
They scored less well in providing sufficient detail on the
methodological approach suitable to the scope (average
score 0.77) as well as detailing limitations of the evaluation
(average score 0.61).
Evaluation coverage
We were able to link approximately 9% (n = 39) of
epidemics with one or more response evaluations
(Table 3). Some evaluation reports (n = 18) covered re-
sponses in multiple countries. A large number of evalua-
tions focused on the same epidemic; for example, 47
evaluations were undertaken to assess the West Africa
Ebola epidemic (2013–2016). There were approximately
equal numbers of post-epidemic (56%) and mid-
epidemic evaluations (44%). The majority of epidemic
response evaluations (87%) were undertaken in coun-
tries which had experienced humanitarian emergen-
cies during the study period. Furthermore, 83% of
response evaluations were undertaken in the WHO
Africa region, 8% in the Eastern Mediterranean region
and the remainder in the Americas region. Two eval-
uations could not be linked to an epidemic as the
epidemic occurred outside of the study period (prior
to 2010).
Coverage of response evaluations varied by disease
(Fig. 3). Ebola epidemics had the highest coverage of
response evaluations with 64% of reported epidemics
having a response evaluation with Lassa fever epidemics
having the lowest coverage (6%). No response evalua-
tions were found for epidemics of anthrax, brucellosis,
diphtheria, hepatitis E, Japanese encephalitis, malaria,
Marburg haemorrhagic fever, Meningococcal disease
and Rift Valley fever epidemics.
Discussion
To our knowledge, this is the first study to systematically
explore the coverage and characteristics of epidemic
evaluations in low resource and humanitarian settings.
The low proportion of epidemics with evidence of
evaluations in settings with low resources and high
needs suggests an inequity [3] requiring urgent address-
ing. The lack of evaluations also points to a deficit in the
accountability to affected populations, a key principle
in humanitarian response [161]. Without the
Fig. 2 Annual availability of response evaluation by epidemic disease compared to total annual epidemics
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availability of rigorous, high quality and standardized
response evaluations, affected populations are unable
to hold responders to account and have no recourse
to redress [29].
The 2-year delay between the onset of an epidemic
and the publication of an evaluation report is a barrier
to efficient dissemination of response findings. Reducing
this delay can potentially be of use in addressing existing
Table 3 Number of epidemic evaluations by pathogen, country, year and whether the evaluation was performed during or after the
epidemic
Disease Country Year Evaluations During epidemic Post epidemic Average quality score Average publication delay (years)
Cholera Benin 2012 1 0 1 42.3 2.0
Cholera Chad 2010 1 1 0 69.2 1.0
Cholera DRC 2012 1 1 0 61.5 2.0
Cholera Guinea 2012 1 0 1 73.1 1.0
Cholera Haiti 2010 8 6 2 77.4 2.8
Cholera Haiti 2012 2 2 0 92.3 3.5
Cholera Haiti 2013 1 0 1 88.5 4.0
Cholera Malawi 2015 2 1 1 88.5 1.0
Cholera Nigeria 2010 1 1 0 69.2 2.0
Cholera Nigeria 2015 1 0 1 96.2 0.0
Cholera Sierra Leone 2012 2 1 1 76.9 1.0
Cholera Somalia 2016 1 1 0 84.6 2.0
Cholera Somalia 2017 1 0 1 92.3 2.0
Cholera South Sudan 2014 1 1 0 92.3 0.0
Cholera South Sudan 2015 1 1 0 96.2 1.0
Cholera Uganda 2015 1 0 1 46.2 1.0
Cholera Yemen 2016 3 2 1 76.9 2.3
Cholera Yemen 2017 2 0 2 96.2 1.0
Ebola DRC 2012 1 0 1 73.1 5.0
Ebola DRC 2018 1 1 0 88.5 1.0
Ebola Guinea 2014 23 10 13 76.7 2.6
Ebola Liberia 2014 36 13 23 73.2 2.2
Ebola Mali 2014 1 0 1 34.6 2.0
Ebola Nigeria 2014 11 5 6 51.3 1.4
Ebola Sierra Leone 2014 47 24 23 77.2 2.1
Ebola Uganda 2012 3 0 3 69.2 1.0
Ebola Uganda 2012 2 0 2 53.9 2.0
Lassa Fever Nigeria 2012 1 0 1 65.4 1.0
Measles Ethiopia 2011 1 0 1 92.3 3.0
Measles Madagascar 2018 1 0 1 92.3 1.0
Plague Madagascar 2017 1 0 1 65.4 1.0
Polio Chad 2011 1 0 1 84.6 3.0
Polio Ethiopia 2013 1 0 1 88.5 5.0
Polio Nigeria 2010 1 1 0 92.3 4.0
Polio Nigeria 2018 1 1 0 65.4 1.0
Polio Somalia 2013 2 0 2 65.4 2.5
Polio Ukraine 2015 1 0 1 80.8 2.0
Yellow fever DRC 2016 1 0 1 84.6 1.0
Yellow fever Uganda 2010 1 0 1 84.6 3.0
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delays in global disease response [162]. More import-
antly, it represents a missed opportunity to enact
changes in a timely manner.
There was considerable variability in the criteria con-
sidered by the evaluations, including quality, coverage,
efficiency, effectiveness, relevance, appropriateness, fidel-
ity or adherence, acceptability and feasibility. Various
combinations of these criteria were used to assess a large
number of response activities. Within a given epidemic
as well as across epidemics, individual evaluations uti-
lized a wide array of differing assessment criteria and
assessed response activities. This variability combined
with a lack of an overarching evaluation framework
makes it difficult to compare evaluations to the same re-
sponse or generalize their conclusions. This finding is
consistent with a previous study on the use of public
health evaluation frameworks in emergencies [1] and un-
derscores a need for an approach and corresponding
toolset that standardizes the evaluation of epidemics in
these settings. We have previously proposed an over-
arching framework for such a unifying approach [1].
The term ‘impact’ was frequently found in the assessed
evaluations, but very few of the assessed evaluations
could be classified as impact evaluations, reflecting the
relatively high technical and resource barriers required
to conduct a robust impact evaluation. Furthermore,
there were marked differences in the number of evalua-
tions by disease pathogen. Whereas one would expect
well-characterized diseases with frequent epidemics to
have the most evaluations, the opposite was largely
found. Approximately two thirds of the Ebola epidemics
recorded had response evaluations compared to 8% of
cholera epidemics and 5% of Lassa fever epidemics. This
is despite the annual attributable deaths due to cholera
being 120,000 [163] and Lassa fever 5000 [164]. This
finding is in line with previous research suggesting that
more severe epidemics or epidemics that threaten large
numbers of people do not necessarily receive more
timely response [162]. The overrepresentation of Ebola
response evaluations is perhaps reflective of a number of
factors such as the unprecedented scale and better re-
sourcing of the response of the West African outbreak.
Superficially, this overrepresentation could perhaps be
due to the poor containment efforts at the outset of the
epidemic leading to international spread and in turn
generating higher international attention and scrutiny.
However, the scale-up and securitization of the response
and subsequent increased scrutiny may have also
reflected the proximity of the epidemic to developed
countries [165, 166].
Implications of this study
The gaps identified in this review are particularly pertin-
ent to future evaluations of the COVID-19 pandemic
which has reached most low-income and humanitarian
settings [167]. Infectious disease epidemics have been
known to exploit and exacerbate social inequalities
within societies for some time [168, 169]. This review
highlights the current global inequality in the response
to these epidemics as gauged by the number of epi-
demics in low-income settings and the paucity of evalu-
ation reports. This nonexistence or lack of publication of
these critical evaluations prevents improvements to fu-
ture public health response. The lack of uniformity of
Fig. 3 Proportion of outbreaks evaluated for each disease. Asterisk indicates no evaluation reports were found for outbreaks of anthrax,
brucellosis, diphtheria, hepatitis E, Japanese encephalitis, malaria, Marburg haemorrhagic fever, Meningococcal disease and Rift Valley fever
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available evaluations limits comparison of the findings
across responses and across time, precluding tracking of
whether epidemic responses do in fact improve over
time, globally or at regional level. The quality limitations
of some of the evaluations hinder the strength of infer-
ence and applicability of their findings. There is a need
to overcome this limitation in order to enable future re-
search to be conducted on the findings of response
valuations. More specifically, future reviews of epidemic
response should attempt to synthesize quantitative ef-
fects of response interventions and may benefit from
SWiM guidelines where appropriate [170].
Limitations
Our study relied overwhelmingly on publicly available
evaluations. It is possible that the disparity between the
number of epidemics, their responses and their subse-
quent evaluations could be overstated as evaluation find-
ings might simply be kept internal and not shared more
widely. However, the effect is largely the same as internal
evaluations are only of benefit to the commissioning
organization and cannot be used more widely. Addition-
ally, we assumed that all epidemics were responded to
and therefore should have been evaluated. However, we
did not know the true proportion of epidemics that were
responded to and therefore could potentially overesti-
mate the gap between evaluations and epidemics. On
the other hand, the use of a 4-month decision rule to
combine multiple reports of epidemics within the same
country could have resulted in an underestimate of the
total number of epidemics and thus an overestimate of
evaluation coverage. We did not look at records that
were not written in English or French and could poten-
tially have missed some evaluations.
Conclusion
The relative paucity of evaluated epidemics, the dispro-
portionate number of evaluations focusing on a limited
number of epidemics together with constrained resource
availability in low-income settings suggests the need for
a governance arrangement or systematic mechanism that
would trigger the conduct of evaluations, no matter
what. The need for strengthening global governance
mechanisms related to infectious disease epidemics and
related challenges have been discussed [171, 172]. We
suggest that arrangements should cover the criteria that
should trigger an evaluation, the timing of evaluation,
the composition and affiliation of the evaluation team,
funding, minimum evaluation standards (e.g. a common
scope and framework) and publication steps.
Approximately 2 billion people live in conflict-affected
or fragile states and are at risk of increased morbidity
and mortality due to epidemics every year. Robust epi-
demic response evaluations seek to improve response
through critically assessing the performance of response
interventions in a given context. However, evaluations of
epidemic response are not a stand-alone activity but ra-
ther must be integrated into a cycle of preparedness and
recovery in order to reach their full utility [173]. The les-
sons learned from an evaluation should concretely sup-
port all responders to better prepare for similar
epidemic and to support health system recovery.
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